Rankings
▼
Calendar
IMUX Q2 2025 Earnings — Immunic, Inc. Revenue & Financial Results | Market Cap Arena
IMUX
Immunic, Inc.
$135M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$27M
Net Income
-$27M
EPS (Diluted)
$-0.20
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$25M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$61M
Total Liabilities
$28M
Stockholders' Equity
$34M
Cash & Equivalents
$55M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$31,000
+100.0%
Operating Income
-$27M
-$23M
-18.7%
Net Income
-$27M
-$21M
-25.4%
← FY 2025
All Quarters
Q3 2025 →